Zymeworks (ZYME) Revenue (2021 - 2026)

Zymeworks has disclosed Revenue across 6 years of filings, most recently posting $2.4 million for Q1 2026.

• Revenue for Q1 2026 came in at $2.4 million, down 22.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.6 million (up 35.3% YoY), and the FY2025 annual result was $106.0 million, up 38.87% from the prior year.
• Revenue came in at $2.4 million for Q1 2026 at Zymeworks, down from $2.5 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $325.0 million in Q4 2022 to a low of $1.9 million in Q1 2022.
• The 5-year median for Revenue is $10.0 million (2024), against an average of $32.8 million.
• Across the five-year window, Revenue surged 3962.5% in 2022 and plunged 94.79% in 2023, its largest moves.
• Zymeworks' Revenue stood at $325.0 million in 2022, then slumped by 94.79% to $16.9 million in 2023, then soared by 83.33% to $31.0 million in 2024, then tumbled by 91.9% to $2.5 million in 2025, then slipped by 4.25% to $2.4 million in 2026.
• The last three Revenue figures came in at $2.4 million (Q1 2026), $2.5 million (Q4 2025), and $25.0 million (Q3 2025), per Business Quant data.